General Information of the Disease (ID: M6ADIS0144)
Name
Endometriosis
ICD
ICD-11: GA10
Full List of Target Gene(s) of This m6A-centered Disease Response
microRNA 126 (MIR126)
In total 1 item(s) under this target gene
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene [4]
Response Summary The METTL3/m6A/miR126 pathway, whose inhibition contributes to endometriosis development by enhancing cellular migration and invasion.
Responsed Disease Endometriosis [ICD-11: GA10]
Target Regulator Methyltransferase-like 3 (METTL3) WRITER
Target Regulation Up regulation
In-vitro Model HESC (Human endometrial stromal cells)
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Disease
In total 4 item(s) under this disease
Crosstalk ID: M6ACROT03081
m6A Regulator RNA demethylase ALKBH5 (ALKBH5)
m6A Target Histone-lysine N-methyltransferase EZH2 (EZH2)
Epigenetic Regulator Histone-lysine N-methyltransferase EZH2 (EZH2)
Regulated Target Histone H3 lysine 27 trimethylation (H3K27me3)
Crosstalk relationship m6A → Histone modification
Crosstalk ID: M6ACROT03082
m6A Regulator YTH domain-containing family protein 2 (YTHDF2)
m6A Target Histone-lysine N-methyltransferase EZH2 (EZH2)
Epigenetic Regulator Histone-lysine N-methyltransferase EZH2 (EZH2)
Regulated Target Histone H3 lysine 27 trimethylation (H3K27me3)
Crosstalk relationship m6A → Histone modification
Crosstalk ID: M6ACROT05304
m6A Regulator Methyltransferase-like 3 (METTL3)
m6A Target Wnt inhibitory factor 1 (WIF1)
Epigenetic Regulator hsa-miR-21-5p
Regulated Target Methyltransferase-like protein 3 (METTL3)
Crosstalk relationship ncRNA → m6A
Crosstalk ID: M6ACROT05595
m6A Regulator Methyltransferase-like 3 (METTL3)
m6A Target microRNA 126 (MIR126)
Epigenetic Regulator MicroRNA 126 (MIR126)
Crosstalk relationship m6A → ncRNA
References
Ref 1 Clinical pipeline report, company report or official report of Astex Pharmaceuticals.
Ref 2 PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine. J Immunother. 2011 Jun;34(5):409-18. doi: 10.1097/CJI.0b013e31821ca6ce.
Ref 3 Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer. Cancer Gene Ther. 2003 Mar;10(3):224-38. doi: 10.1038/sj.cgt.7700562.
Ref 4 Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis?. Biol Reprod. 2021 Nov 15;105(5):1221-1233. doi: 10.1093/biolre/ioab152.
Ref 5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1875).